Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Avantogen Oncology, Inc.    AVTO

AVANTOGEN ONCOLOGY, INC. (AVTO)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 02/16 03:30:05 pm
0.012 USD   --.--%
 SummaryQuotesChartsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
11/28/2017 12/19/2017 01/09/2018 02/08/2018 02/16/2018 Date
0(c) 0.005(c) 0.006(c) 0.012(c) 0.012(c) Last
3 100 20 000 9 662 2 400 Volume
-100.00% +20.00% +100.00% 0.00% Change
More quotes
Company
Avantogen Oncology, Inc. operates as a development stage company.It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer.The company was founded in 1986 and is headquartered in Los Angeles, CA. 
More about the company
Latest news on AVANTOGEN ONCOLOGY, INC.

- No features available -

More news
Sector news : Biotechnology & Medical Research - NEC
02/15French pharma group Ipsen sees more asset purchases, U.S. growth
RE
02/15Oxford BioMedica wins second $100 million gene therapy contract
RE
02/14Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
RE
02/14BRISTOL MYERS SQUIBB : Nektar to Partner on Cancer Therapy
DJ
02/13Drug copies ready to take next bite out of Roche's cancer sales
RE
More sector news : Biotechnology & Medical Research - NEC
Chart AVANTOGEN ONCOLOGY, INC.
Duration : Period :
Avantogen Oncology, Inc. Technical Analysis Chart | AVTO | US05350Y1001 | 4-Traders
Managers
NameTitle
William J. Ardrey Chairman, President & Chief Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
AVANTOGEN ONCOLOGY, INC.140.00%0
CELLTRION, INC.--.--%36 110
IQVIA HOLDINGS INC6.93%21 125
LONZA GROUP-7.82%18 606
INCYTE CORPORATION-6.91%18 063
NEKTAR THERAPEUTICS40.66%13 227